LPA and myocardial infarction: The risk of coronary death, myocardial infarction (MI) and coronary revascularization were reduced by 23% in patients with baseline Lp(a) > median (37 nmol/L equal to 13 mg/dL), while in individuals with baseline Lp(a) < median the risk reduction was only 7% (Table 2).